Pfizer has cut 72 jobs at its Pearl River, New York facility. Workers in Pfizer’s chemical Division at Pearl River will be laid off by May 21. Pfizer has already laid off 483 of 3,000 workers since October 15. Pfizer may lay off more employees in coming months depending on whether they close the manufacturing [...]
Continue reading...Saturday, January 9, 2010
Pharmaceutical powerhouse, Pfizer, announced yesterday that it would be cutting a total of 680 jobs from it’s Collegeville and Great Valley campuses. The layoffs had been expected ever since Pfizer Inc. purchased rival Wyeth back in October. The Collegeville and Great Valley campuses were once major Wyeth operations. Gwen Fisher, a spokeswoman for Pfizer told told [...]
Continue reading...Monday, November 9, 2009
Pfizer is cutting 600 jobs in St Louis as part of a restructuring being done in the wake of its purchase of drug and vaccine maker Wyeth. Pfizer acquired Wyeth in mid October and is consolidating its R&D program company wide. Some layoffs will occur immediately with the rest spread out through 2011. [...]
Continue reading...Sunday, February 1, 2009
UK pharmaceutical company GlaxoSmithKline will announce about 6,000 job losses when it posts results this week, the Sunday Telegraph newspaper reports. The cuts by Glaxo, the world’s second largest drug company after Pfizer, are part of CEO Andrew Witty’s strategy to meet increased competition from generic drug makers. The company, which employs about 100,000 people globally, has [...]
Continue reading...Thursday, January 29, 2009
Mass Layoffs, which are layoffs involving 50 or more workers, increased by one third in 2008. The rapidity of these mass layoffs has increased even more in the early days of 2009. According to the Labor Department, 21,137 mass layoffs happened last year. That’s compared to 15,493 in 2007. It’s the highest annual total since 2001 [...]
Continue reading...Tuesday, January 27, 2009
Drug Company Pfizer has a $68 billion plan to buy out Wyeth, another big drug company. Some think the merger is exactly what Wall Street needs. However, in addition to its potential healing effects on wall street, it is likely to negatively effect the New York region, as it will probably result in thousands of layoffs [...]
Continue reading...Monday, January 26, 2009
Brooklyn pharmaceutical giant Pfizer will acquire rival Wyeth for $68 billion. The boards of directors of both companies have approved the deal. Pfizer will cut more than 8,000 jobs in anticipation of cholesterol drug Lipitor losing patent protection in 2011. Pfizer said it would cut 10% of its staff and close five of its manufacturing plants. [...]
Continue reading...
Tuesday, February 23, 2010
1 Comment